ECSS
DGX icon

Eurizon Capital SGR SpA’s Quest Diagnostics DGX Stock Holding History

Eurizon Capital SGR SpA’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.2M Sell
222,564
-18,252
-8% -$3.58M 0.13% 141
2026
Q1 		$47.2M Sell
240,816
-8,366
-3% -$1.63M 0.15% 137
2025
Q4 		$43.2M Buy
+249,182
New +$45.4M 0.13% 127

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Eurizon Capital SGR SpA's DGX Position: Q2 2026 in Review

Eurizon Capital SGR SpA reduced its Quest Diagnostics (DGX) stake by 7.6% in Q2 2026, selling an estimated $3.58M and leaving 222,564 shares worth $47.2M. The position accounts for 0.13% of the portfolio, ranked #141.

Eurizon Capital SGR SpA first reported a position in DGX in Q4 2025 and has held it in 3 quarters since. The position peaked at $47.2M in Q1 2026. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Eurizon Capital SGR SpA held 222,564 shares of Quest Diagnostics worth $47.2M as of Q2 2026.
  • Eurizon Capital SGR SpA sold 18,252 Quest Diagnostics shares in Q2 2026, an estimated $3.58M.
  • Quest Diagnostics made up 0.13% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #141 holding.
  • Eurizon Capital SGR SpA first reported a position in Quest Diagnostics in Q4 2025 and has held it in 3 quarters since.
  • Eurizon Capital SGR SpA's Quest Diagnostics position peaked at $47.2M in Q1 2026.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.